Dublin, Dec. 18, 2017 (GLOBE NEWSWIRE) -- The "Apheresis Equipment - Global Strategic Business Report" report has been added to Research and Markets' offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Apheresis Equipment in US$ Thousand by the following Type of Apheresis Equipment:
- Equipment for Therapeutic Apheresis
- Equipment for Donor Apheresis.
The Global market is additionally analyzed by the following Procedures:
- Photopheresis
- Plasmapheresis
- Others
The report profiles 14 companies including many key and niche players such as:
- Asahi Kasei Medical Co., Ltd. (Japan)
- B Braun Melsungen AG (Germany)
- Cerus Corporation (USA)
- Fresenius Kabi (Germany)
- Haemonetics Corporation (USA)
- Kaneka Corporation (Japan)
- Kawasumi Laboratories, Inc. (Japan)
- Mallinckrodt Pharmaceuticals (Ireland)
- Medica SpA (Italy)
- NIKKISO Europe GmbH (Germany)
- Terumo BCT, Inc. (USA)
Key Topics Covered:
1. INDUSTRY OVERVIEW
Apheresis Equipment - Rising Adoption of Therapeutic and Donor Apheresis Favors Growth
Donor Apheresis & Therapeutic Apheresis
Donor Apheresis: Dominating Equipment Sales
Therapeutic Apheresis to Witness Strong Growth
Disposable Apheresis Kits Market Benefits from Single-Use Nature of Products
Centrifugation Technology Continues to Lead, Membrane Filtration Promises Growth
Plasmapheresis Systems Dominate Apheresis Equipment Market
Neurology - The Major Application Area for Apheresis Equipment
Developed Markets Continue to Lead Apheresis Equipment Market
Developing Nations to Lead the Charge in Future
Rising Demand for Plasma from Biopharmaceutical Companies
Opportunity to Tap
Sustained Growth in Blood Collections Favors Apheresis Equipment Market
Competitive Landscape
Consolidation of Blood Collectors & Healthcare Providers Puts Pricing Pressure on Suppliers
2. KEY MARKET TRENDS & DRIVERS
Rising Cancer Incidence to Drive Volume of Apheresis Procedures
Technological Advancements and Novel Indications Augur Well for Apheresis Market
Blood Supply Shortage & Safety Concerns Bode Well for Apheresis Market
Photopheresis: A Popular Therapeutic Apheresis Procedure
Plasmapheresis Continues to Lead the Apheresis Market
Plateletpheresis Emerges as the Treatment of Choice'
Increase in Number of Platelet Donors Drives Apheresis Procedures
Pediatrics: An Unexplored Domain in Therapeutic Apheresis
Automated Blood Processing Systems in Open Heart Surgeries
CFA - An Effective Way to Pull Up Cold Hemagglutinin Disease
Improving Healthcare Expenditure to Drive Demand
Aging Population: A Strong Growth Driver
Key Challenges & Issues
Lack of Awareness among Patients Restrains Market Growth
Vendors' Attitude Hampers Growth Prospects of Therapeutic Apheresis
Development of Inexpensive Apheresis Therapies
Shortage of Qualified Donors
Challenges for Therapeutic Apheresis in the Unexplored Pediatrics Segment
3. TECHNOLOGY OVERVIEW
Apheresis - The Definition
Apheresis Vs Whole Blood Collection
Comparison of Apheresis and Whole Blood Collection
The Process of Apheresis - An Overview
Blood Components
Apheresis Procedure
Duration, Frequency, and Efficiency of Apheresis
Segregation of Blood Components
Centrifugation
Centrifugal Cell Separators
Filtration
Side Effects
Types of Apheresis Procedures
Plasmapheresis
Plasma Exchange and Plasmapheresis: The Difference
Therapeutic Plasma Exchange (TPE) or Plasma Exchange
TPE: Abnormal Components Removed from Blood
Plasmapheresis: Potential Uses Discovered in the Early Years
Potential Use of Plasmapheresis in Select Diseases Discovered in the Early Years
Erythrocytapheresis
Plateletpheresis
Leukapheresis
Photopheresis
Functioning of THERAKOS - A Typical Photopheresis System
Lipidpheresis
Cytapheresis
Stem Cell Collection
Apheresis - A Review of Segmentation
Donor Apheresis
Process of Donor Apheresis
Automated Blood Donation Procedures
Safety of the Donor
Blood Components Required by Different Patients
Automated Apheresis
Therapeutic Apheresis: An Introduction
Therapeutic Apheresis Techniques
Applications of Therapeutic Apheresis
Categories of Indications for Therapeutic Apheresis
Therapeutic Apheresis is Remedial for Various Diseases
Indications for Therapeutic Apheresis
Type of Therapeutic Apheresis Procedure Used in Different Medication Conditions
Emerging Applications of Therapeutic Apheresis
Cost of Select Therapeutic Apheresis Procedures: An Overview
1. Photopheresis in GVHD (Graft-Versus-Host Disease)
2. Lipid Apheresis (LDL Apheresis)
3. Plasmapheresis and Other Procedures
Therapeutic Apheresis: What is the Risk Involved?
Replacement Fluid in Therapeutic Apheresis
Replacement Fluids Used in Therapeutic Apheresis
Various Replacement Fluids in Use
Select Replacement Fluids and their Limitations
Complications Involved and Suggested Treatment in the Therapeutic Apheresis Procedure
Therapeutic Plasmapheresis with Fresh Frozen Plasma (FFP) Replacement
4. BLOOD COMPONENTS & DERIVATIVES
Red Blood Cells (RBCs)
White Blood Cells (WBCs)
Platelets
Sources of Blood Plasma
Facts About Plasma and its Donation
Pre-requisites for Plasma Donors
The Complex Process of Becoming a Donor
Medical Screening
The Process of Plasma Donation
Select IQPP-authorized Plasma Collection Centers (US)
Ionic Composition of Blood
Types of Blood
General Facts about Blood
General Uses of Blood
Blood - Global Facts
5. PRODUCT INNOVATIONS/INTRODUCTIONS
Fresenius Introduces 6008 CAREsystem
Terumo BCT Launches Correct Connect System
FDA Approves IDE Supplement for Cerus' INTERCEPT Blood System
Health Canada Approves WBCD and PMN Cell Collection Protocols for Spectra Optia
USFDA Clears PMN Protocol for Terumo's Spectra Optia
6. RECENT INDUSTRY ACTIVITY
Haemonetics Gains FDA Approval for NexSys PCS Plasmapheresis System
Terumo BCT Receives CE Mark for Spectra Optia Apheresis System
Terumo BCT Enters into Distribution Agreement with B Medical Systems
Mallinckrodt Takes Over Therakos
HemaCare Sells Therapeutic Apheresis Assets to Fresenius
Terumo BCT Files FDA Submission to Improve Blood Supply Safety
Fenwal Autopheresis-C Instruments Donated for Ebola Virus Study
Terumo opens Production Facility in Vietnam
Terumo Collaborates with Kaneka
Terumo to Distribute Therakos Products in Latin America
Terumo Enters Distribution Agreement with Therakos
7. FOCUS ON SELECT PLAYERS
Asahi Kasei Medical Co., Ltd. (Japan)
B Braun Melsungen AG (Germany)
Cerus Corporation (USA)
Fresenius Kabi (Germany)
Haemonetics Corporation (USA)
Kaneka Corporation (Japan)
Kawasumi Laboratories, Inc. (Japan)
Mallinckrodt Pharmaceuticals (Ireland)
Medica SpA (Italy)
NIKKISO Europe GmbH (Germany)
Terumo BCT, Inc. (USA)
8. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 14 (including Divisions/Subsidiaries - 20)
- The United States (8)
- Japan (3)
- Europe (9)
- Germany (5)
- Italy (3)
- Rest of Europe (1)
For more information about this report visit https://www.researchandmarkets.com/research/dppxpj/apheresis?w=12